Modifies provisions relating to gender transition

Children

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Moon, Mike; House handler: N/A
Last action: 2026-04-08
Official status: Voted Do Pass S Families, Seniors and Health Committee
Effective date: 2026-08-28

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

2026-04-08 Missouri House of Representatives and Missouri Senate
Voted Do Pass S Families, Seniors and Health Committee
2026-01-28 Missouri House of Representatives and Missouri Senate
Hearing Conducted S Families, Seniors and Health Committee
2026-01-08 S125
Second Read and Referred S Families, Seniors and Health Committee
2026-01-07 S37
S First Read
2025-12-01 Missouri House of Representatives and Missouri Senate
Prefiled

Official Summary Text

The following summaries of this bill are available:

Print All Summaries

Introduced

Print

SB 861 - Under this act, and unless clearly and specifically stated otherwise, the term "reproductive health care", as used in the laws and regulations of this state, shall not be construed to include gender transition surgeries or the use of cross-sex hormones or puberty-blocking drugs for the purpose of gender transition for minor children or adults.

This provision is identical to SB 26 (2025), SB 1459 (2024), and HB 2830 (2024).

Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date.

This provision is identical to provisions in SB 26 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).
SARAH HASKINS